Acute rhabdomyolysis during the treatment of scleromyxedema with interferon alfa

Citation
F. Ozdag et al., Acute rhabdomyolysis during the treatment of scleromyxedema with interferon alfa, J DERM TR, 12(3), 2001, pp. 167-169
Citations number
10
Categorie Soggetti
Dermatology
Journal title
JOURNAL OF DERMATOLOGICAL TREATMENT
ISSN journal
09546634 → ACNP
Volume
12
Issue
3
Year of publication
2001
Pages
167 - 169
Database
ISI
SICI code
0954-6634(200109)12:3<167:ARDTTO>2.0.ZU;2-X
Abstract
A 34-year-old white man developed acute rhabdomyolysis during the treatment of scleromyxedema with interferon alfa. If interferon alfa is to be used a s a therapeutic option for scleromyxedema the possibility of rhabdomyolysis should be considered. To the best of our knowledge, this is the first case in which acute rhabdomyolysis was developed during the treatment of sclero myxedema with interferon alfa.